The IMPACCT Rapid Program is a collaborative international quality improvement program that studies the prospective use of medications and non-pharmacological interventions commonly used in palliative care and cancer symptom management.

o6iRz2rYsSE

Transcript

Professor Meera Agar: The National Palliative Care Strategy really gives direction for both Commonwealth, State and Territory governments about how to deliver high-quality palliative care to all Australians, and it really provides the direction and the accountability to achieve that.

The RAPID Program is an international program which works with clinicians across the world to develop a program in quality improvement to assess interventions that are commonly used in palliative care. It's based on a methodology called post-marketing surveillance or Phase 4 methodology. It allows us to understand the harms and the benefits of interventions in the real world to really inform clinical care.

Clinicians working in palliative care should get involved in the RAPID Program for two reasons. One is at the beginning of a series, one gets to meet with interdisciplinary clinicians and debate what benefits and harms should be included in the data collection and why that might be. The second is that you then get to understand the real-world data from that series and think about how that might affect your clinical practice and where improvements can be made.

The National Palliative Care Strategy asks us to make sure that quality improvement is built into the way we build services, and so research and data are really critical to underpin the National Palliative Care Strategy. So RAPID is really contributing directly to provide meaningful data from real-world practice that's going to inform that goal.

Why Rapid?

The program is called Rapid because it involves:

  • Rapid data collection
  • Rapid collation and analysis
  • Rapid reporting
  • Rapid influence on clinical practice